Delineation of multiple deleted regions in 7q in myeloid disorders

Genes Chromosomes and Cancer

Volumn 25, Issue 4, 1999, Pages 384-392

  Tosi, Sabrina ^a   Scherer, Stephen W ^d   Giudici, Giovanni ^b   Czepulkowski, Barbara ^c   Biondi, Andrea ^b   Kearney, Lyndal ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 7Q; CHROMOSOME DELETION; CHROMOSOME MAP; CLINICAL ARTICLE; DISEASE ASSOCIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOSS; GENE SEQUENCE; HUMAN; HUMAN CELL; METAPHASE CHROMOSOME; MYELOID LEUKEMIA; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; CHILD; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INVERSION, CHROMOSOME; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032795454     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199908)25:4<384::AID-GCC11>3.0.CO;2-D     Document Type: Article

References (26)

1. Buckle VJ, Rack K. 1993. Fluorescent in situ hybridization. In Davies KE, editor. Human genetic disease analysis, Oxford: IRL Press, p 59-82.
2. Fischer K, Fröhling S, Scherer SW, McAllister Brown J, Scholl C, Stilgenbauer S, Tsui L-C, Lichter P, Döhner H. 1997. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in mycloid leukemias. Blood 89:2036-2041.
3. Glockner G, Scherer SW, Schattevoy R, Boright A, Weber J, Tsui L-C, Rosenthal A. 1998. Large scale analysis of two regions in human 7q22: analysis of 650 kb of genomic sequence around the EPO and CUTL1 loci reveals 17 genes. Genome Res 8:1060-1073.
4. Hashim Y, Ragoussis I, Kearney L, Tosi S, So AK. 1995. Physical mapping of the human T-cell antigen receptor β-gene complex using yeast artificial chromosomes. Immunogenetics 41:337-342.
5. Huang H, Qian C, Jenkins RB, Smith DI. 1998. FISH mapping of YAC clones at human chromosomal band 7q31.2: identification of YACS spanning FRA7G with the common region of LOH in breast and prostate cancer. Genes Chromosomes Cancer 21:152-159.
6. Ishwad CS, Ferrell RE, Hanley K, Davare J, Meloni AM, Sandberg AA, Surti U. 1997. Two discrete regions of deletion at 7q in uterine leiomyomas. Genes Chromosomes Cancer 19:156-160.
7. Johnson EJ, Scherer SW, Osborne L, Tsui LC, Oscier D, Mould S, Cotter FE. 1996. Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood 87:3579-3586.
8. Kere J, Ruutu T, Davies KA, Roninson IB, Watkins PC, Winqvist R, de la Chapelle A. 1989a. Chromosome 7 long arm deletion in myeloid disorders: a narrow breakpoint region in 7q22 defined by molecular mapping. Blood 73:230-234.
9. Kere J, Donis-Keller H, Ruutu T, de la Chapelle A. 1989b. Chromosome 7 long-arm deletions in myeloid disorders: terminal DNA sequences are commonly conserved and breakpoints vary. Cytogenet Cell Genet 50:226-229.
10. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD. 1986. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 3:325-345.
11. Le Beau MM, Espinosa RI, Davis EM, Eisenbart JD, Larson RA, Green ED. 1996. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant mycloid diseases. Blood 88:1930-1935.
12. Lewis S, Abrahamson G, Boultwood J, Fidler C, Potter A, Wainscoat JS. 1996. Molecular characterization of the 7q deletion in myeloid disorders. Br J Haematol 93:75-80.
13. Neuman WL, Rubin CM, Rios RB, Larson RA, Le Beau MM, Rowley JD, Vardiman JW, Schwartz JL, Farber RA. 1992. Chromosomal loss and deletion are the most common mechanisms for loss of heterozygoticity from chromosomes 5 and 7 in malignant mycloid disorders. Blood 79:1501-1510.
14. Nicolaides NC, Papadopoulos N, Liu B, Wei VF, Carter KC, Ruben SM, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Dunlop MG, Hamilton SR, Petersen GM, de la Chapelle A, Volgestein B, Kinzler KW. 1994. Mutation of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371:75-80.
15. Nicolaides NC, Carter KC, Shell BK, Papadopoulos N, Volgestein B, Kinzler KW. 1995. Genomic organization of the human PMS2 gene family. Genomics 30:195-206.
16. Osborne LR, Herbrick J-A, Greavette T, Heng HHQ, Tsui L-C, Scherer SW. 1997. PMS2-related genes flank the rearrangement breakpoints associated with Williams syndrome and other diseases on human chromosome 7. Genomics 45:402-406.
17. Pedersen B, Ellegaard J. 1994. A factor encoded by 7q31 suppresses expansion of the 7q-clone and delays cytogenetic progression. Cancer Genet Cytogenet. 78:181-188.
18. Pedersen-Bjergaard J, Rowley JD. 1994. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780-2786.
19. Rambaldi A, Bettoni S, Tosi S, Giudici G, Schiró R, Borleri GM, Abbate M, Chiaffarino F, Colotta F, Barbui T, Biondi A. 1993. Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8). Blood 81:1376-1383.
20. Skalnik DG, Strauss EC, Orkin SH. 1991. CCAAT displacement protein as a repressor of the myelonomonocytic-specific gp91-phox gene promoter. J Biol Chem 266:16736-16744.
21. Tosi S, Harbott J, Haas OA, Douglas A, Hughes DM, Ross FM, Biondi A, Scherer SW, Kearney L. 1996. Classification of deletions and identification of cryptic translocations involving 7q by fluoresence in situ hybridization (FISH). Leukemia 10:644-649.
22. Tosi S, Guidici G, Mosna G, Harbott J, Specchia G, Grosveld G, Privitera E, Kearney L, Biondi A, Cazzaniga G. 1998. Identification of new partner chromosomes involved in fusions with the ETV6 (Tel.) gene in hematologic malignancies. Gene Chromosomes Cancer 21:223-229.
23. Tosi S, Giudici G, Rambaldi A, Scherer SW, Bray-Ward P, Dirscherl L, Biondi A, Kearney L. 1999. Characterization of the human mycloid leukemia-derived cell line GF-D8 by multiplex fluorescence in situ hybridization, subtelomeric probes and comparative genomic hybridization. Genes Chromosomes Cancer 24:213-221.
24. Yokouchi M, Suzuki R, Masuhara M, Komiya S, Inoue A, Yoshimura A. 1997. Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. Oncogene 15:7-15.
25. Zeng WR, Scherer SW, Koutsilieris M, Huizenga JJ, Filteau F, Tsui L-C, Ncpveu A. 1997. Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas. Oncogene 14:2355-2365.
26. Zenklusen JC, Conti C. 1996. Cytogenetic, molecular, and functional evidence for novel tumor suppressor genes on the long arm of human chromosome 7. Mol Carcinog 15:167-175.